Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Nymox discovers new treatment for E. coli 0157:H7 infection

Sep. 8, 1998

New antibacterial/antitumor agents produced by fungal strains discovered by Kyowa Hakko

Sep. 8, 1998

Broad-spectrum parenteral cephalosporin launched this week in Japan

Sep. 7, 1998

Maracenines: isolation and characterization of new antibacterial agents

Sep. 7, 1998

Antimicrobial polypeptides claimed by Fujisawa for infectious diseases

Sep. 4, 1998

Potent new antimalarial trioxanes developed at Johns Hopkins

Sep. 2, 1998

Mylan acquires U.S. marketing rights to Zagam

Sep. 1, 1998

RiboGene and EnzyMed to collaborate on antiinfective drug discovery

Sep. 1, 1998

Highly active and stable new carbapenems described by Meiji Seika

Aug. 31, 1998

New cephalosporin derivatives active against MRSA

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...